AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1440804
Drug: Mefloquine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine 15 mg/kg
Trial: 1440804
Drug: Mefloquine 25
RxNorm normalized name: mefloquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine 25 mg/kg
Trial: 31083855
Drug: Tele-nursing follow-up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tele-nursing follow-up (phone by nurses for 12 weeks, twice a week for the first month and once a week for the following two months)
Trial: 27431234
Drug: Tribendimidine 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribendimidine 400 mg
Trial: 27431234
Drug: Tribendimidine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribendimidine (various doses)
Trial: 27431234
Drug: Tribendimidine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribendimidine (25 to 200 mg)
Trial: 24762684
Drug: Non-bismuth quadruple
RxNorm normalized name: bismuth
DrugBank: Bismuth cation (DB14572)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-bismuth quadruple therapy for 7 days (esomeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg, tinidazole 500 mg given twice daily)
Trial: 24762684
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy for 7 days (esomeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg given twice daily)
Trial: 24762684
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy for 10 days (esomeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg given twice daily)
Trial: 24762684
Drug: Non-bismuth quadruple
RxNorm normalized name: bismuth
DrugBank: Bismuth cation (DB14572)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-bismuth quadruple therapy
Trial: 24762684
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy for 7 days
Trial: 22356304
Drug: Sucralfate-steroid retention
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate-steroid retention enema
Trial: 16183654
Drug: Postcards intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postcards intervention (eight postcards over 12 months) along with standard treatment
Trial: 1795055
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine gluconate (CHX) solution
Trial: 1795055
Drug: 0.025% amine‐stannous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025% amine‐stannous fluoride (AmF + SnF) solution
Trial: 1795055
Drug: 0.05% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% sodium fluoride (F) solution
Trial: 7236870
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg oral dose of 'Inderal' tablet (conventional formulation)
Trial: 7236870
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release formulation 'Inderal' LA
Trial: 7236870
Drug: Clinical trial
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical trial sustained release formulation
Trial: 7236870
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release formulations (both)
Trial: 25943394
Drug: Metformin (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (with supplemental insulin if required)
Trial: 22509859
Drug: Biphasic insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic insulin aspart 70/30 (BIAsp 30)
Trial: 19095875
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL saline (control group)
Trial: 19095875
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tramadol and 2 mL saline (TL group)
Trial: 7029292
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with Adriamycin and cyclophosphamide (Cytoxan) in soft tissue sarcomas
Trial: 7029292
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate following surgery in osteogenic sarcoma
Trial: 31758920
Drug: Drospirenone (DRSP)
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Drospirenone (DRSP) 4 mg
Trial: 27596027
Drug: Web-based physiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based physiotherapy (8 weeks, twice per week)
Trial: 25245489
Drug: Pentosan polysulfate
RxNorm normalized name: Pentosan polysulfate
DrugBank: Pentosan polysulfate (DB00686)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentosan polysulfate sodium 100 mg once daily
Trial: 25245489
Drug: Pentosan polysulfate
RxNorm normalized name: Pentosan polysulfate
DrugBank: Pentosan polysulfate (DB00686)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentosan polysulfate sodium 100 mg three times daily
Trial: 23588794
Drug: Subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous sumatriptan injection (6 mg)
Trial: 31622374
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg D-cycloserine (DCS)
Trial: 21301814
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg D-cycloserine (DCS) with partial smoking
Trial: 18973950
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) with intravenous verteporfin at 6 mg/m² body surface, laser beam applied at radiant exposure 50 J/cm² for 83 seconds, 1 to 4 treatments at 12-week intervals over 1 year.
Trial: 11770871
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment for > or = 6 months before hospital admission
Trial: 8077738
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day of parenteral clindamycin (standard prophylaxis)
Trial: 8077738
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day of topical clindamycin
Trial: 8077738
Drug: 5 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 days of topical clindamycin
Trial: 8077738
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day of topical amoxicillin plus clavulanate/ticarcillin plus clavulanate
Trial: 28719305
Drug: Monthly visits
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly visits from sales agents
Trial: 26272768
Drug: Rolapitant (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolapitant (180 mg dose)
Trial: 7044294
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of chlorpheniramine
Trial: 22719016
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of chlorpheniramine-200 mg of caffeine
Trial: 21754985
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (VPA) and L-carnitine for 12 months
Trial: 11782819
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg valdecoxib twice daily
Trial: 11782819
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg valdecoxib twice daily
Trial: 8590611
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) 100 mg, PO, tid
Trial: 8590611
Drug: Standard detoxification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard detoxification therapy
Trial: 8590611
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) 50-100 mg, bid-tid after acute withdrawal
Trial: 2492178
Drug: Bilateral myringotomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral myringotomy and no additional treatment (group 1)
Trial: 1091151
Drug: Adenine arabinoside
RxNorm normalized name: Adenine
DrugBank: Adenine (DB00173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenine arabinoside 20 mg/kg/day intravenous infusions for seven days
Trial: 27281720
Drug: Intraneural injection
RxNorm normalized name: bleomycin
DrugBank: Bleomycin (DB00290)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraneural injection (group INTRA)
Trial: 27281720
Drug: Subparaneural injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subparaneural injection (group SUBPARA)
Trial: 15485437
Drug: Digitalis and
RxNorm normalized name: Digitalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digitalis and beta-blocker during isoproterenol infusion
Trial: 9753263
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg twice daily for six months
Trial: 7826831
Drug: 97 mg
RxNorm normalized name: kaolin 197 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 97 mg amoxycillin sodium (0.25 mmol)
Trial: 7826831
Drug: 3103 mg
RxNorm normalized name: Mg
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3103 mg amoxycillin sodium (8 mmol)
Trial: 30197311
Drug: Verapamil injection
RxNorm normalized name: verapamil Injection
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Verapamil injection (2 mL) around the anastomosis site before and after surgery (2, 4, 6, 8, and 10 weeks after surgery)
Trial: 27185164
Drug: FP/FORM (100/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP/FORM (100/10 µg b.i.d.)
Trial: 27185164
Drug: FP/SAL (100/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP/SAL (100/50 µg b.i.d.)
Trial: 24190232
Drug: MSUS-guided injection
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSUS-guided injection of 40 mg of methylprednisolone acetate (Group 2, n = 59)
Trial: 24190232
Drug: Palpation-guided injection
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palpation-guided injection (Group 1, n = 66)
Trial: 18717680
Drug: 5-aminolaevulinic acid-photodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-aminolaevulinic acid-photodynamic therapy (ALA-PDT)
Trial: 16282192
Drug: Cannabis-based medicine
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis-based medicine (Sativex)
Trial: 1389816
Drug: 0.5% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% plain bupivacaine administered at a speed of 10 seconds
Trial: 1389816
Drug: 0.5% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% plain bupivacaine administered at a speed of 180 seconds
Trial: 26626719
Drug: Once-daily tobramycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily tobramycin inhalation solution (TIS) 300 mg/5 mL
Trial: 26626719
Drug: Twice-daily tobramycin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily tobramycin inhalation solution (TIS) 300 mg/5 mL
Trial: 26626719
Drug: Once-daily versus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily versus twice-daily tobramycin inhalation solution (TIS)
Trial: 26626719
Drug: Both once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both once-daily and twice-daily tobramycin inhalation solution (TIS)
Trial: 24960387
Drug: Listerine Cool
RxNorm normalized name: Listerine Cool Mint Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Listerine Cool Blue Agent
Trial: 1977330
Drug: Sufentanil (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (1 microgram/kg) and Vecuronium (0.2 mg/kg)
Trial: 1977330
Drug: Sufentanil (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (1 microgram/kg) and Atracurium (1.0 mg/kg)
Trial: 1977330
Drug: Fentanyl (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (5 micrograms/kg) and Vecuronium (0.2 mg/kg)
Trial: 1977330
Drug: Fentanyl (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (5 micrograms/kg) and Atracurium (1.0 mg/kg)
Trial: 31862277
Drug: Jacobson's relaxation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jacobson's relaxation technique (20‐30min daily for three consecutive days)
Trial: 31862277
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care and treatment (control group)
Trial: 30087153
Drug: 10 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL/kg fluid bolus every 15 min for up to 4 hours
Trial: 30087153
Drug: 20 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL/kg fluid bolus every 15 min for up to 4 hours
Trial: 25741969
Drug: Short-course ARV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course ARV (antenatal zidovudine with single-dose nevirapine)
Trial: 23506731
Drug: Tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine ER (4 mg) daily
Trial: 20021912
Drug: 0.15 U/(kg.d)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 U/(kg.d) growth hormone (Somatropin, S19990021) in A(1) and B(1) groups
Trial: 20021912
Drug: 0.2 U/(kg.d)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 U/(kg.d) growth hormone in A(2) and B(2) groups
Trial: 20021912
Drug: No growth
RxNorm normalized name: Mechano growth factor
DrugBank: Mecasermin (DB01277)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: No growth hormone (NS) in A(0) and B(0) groups
Trial: 20021912
Drug: 0.15 U/(kg.d)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 U/(kg.d) growth hormone in A(1) and B(1) groups
Trial: 9120921
Drug: Fat injections
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat injections
Trial: 9120921
Drug: Collagen injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen injections
Trial: 8443252
Drug: Weekly telephone
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly telephone survey
Trial: 3537462
Drug: Medical Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical Therapy (N = 10)
Trial: 29030503
Drug: Blended therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blended therapy
Trial: 31419322
Drug: DTPw (cellular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw (cellular Bordetella pertussis vaccine)
Trial: 31419322
Drug: DTPa (acellular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa (acellular Bordetella pertussis vaccine)
Trial: 26409158
Drug: Acceptance &
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance & Commitment Therapy (ACT)
Trial: 21300246
Drug: Inadequate pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inadequate pretreatment oral hygiene
Trial: 19741484
Drug: Propofol (0-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0-12 microg/ml) and Sevoflurane (0-3.5 vol.%)
Trial: 19741484
Drug: Propofol (0-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0-12 microg/ml)
Trial: 11352440
Drug: Moxifloxacin 400mg
RxNorm normalized name: moxifloxacin 400 MG
DrugBank: Moxifloxacin (DB00218)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400mg administered orally after 250g of yoghurt
Trial: 11352440
Drug: Moxifloxacin 400mg
RxNorm normalized name: moxifloxacin 400 MG
DrugBank: Moxifloxacin (DB00218)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400mg administered orally under fasting conditions
Trial: 8200006
Drug: Single high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high dose dactinomycin (60 mcg/kg x 1 day)
Trial: 8200006
Drug: Standard fractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fractionated dactinomycin (15 mcg/kg x 5 days)
Trial: 2965631
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic peptide (ANP) infusion at 0.4 pmol min-1 kg-1
Trial: 2965631
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic peptide (ANP) infusion at 2 pmol min-1 kg-1
Trial: 2965631
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic peptide (ANP) infusion at 10 pmol min-1 kg-1
Trial: 24640666
Drug: levofloxacin (Glevo)
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: levofloxacin (Glevo) 500 mg/day
Trial: 24640666
Drug: original levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: original levofloxacin 500 mg/day
Trial: 19178516
Drug: Octreotide LAR
RxNorm normalized name: octreotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide LAR 20 mg every 28 days
Trial: 15538079
Drug: Oral antioxidants
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antioxidants (oxygenated carotenoid - lutein)
Trial: 9642972
Drug: Clonazepam (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (1.5 to 3 mg daily)
Trial: 2954800
Drug: Partially purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially purified bovine/porcine insulin
Trial: 23902631
Drug: Active deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active deep brain stimulation to the ventral striatum/anterior limb of the internal capsule
Trial: 20570290
Drug: Cefazolin continuous
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin continuous infusion (1 g every 6 hours for 18 hours after an initial 2 g dose)
Trial: 20570290
Drug: Cefazolin intermittent
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin intermittent administration (1 g at 3, 9, and 15 hours after an initial 2 g dose)
Trial: 20570290
Drug: Cefazolin continuous
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin continuous infusion
Trial: 20570290
Drug: Cefazolin intermittent
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin intermittent administration
Trial: 12124550
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 50 mg orally every 8 hours
Trial: 12124550
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no steroids or NSAIDs)
Trial: 9585797
Drug: 80 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/day ipsapirone CR
Trial: 9585797
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day fluoxetine
Trial: 7635364
Drug: Intrauterine insemination
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine insemination (IUI) with 0.5 ml of inseminate
Trial: 7635364
Drug: Fallopian sperm
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fallopian sperm perfusion (FSP) with 4 ml of inseminate
Trial: 408844
Drug: l-amphetamine 10
RxNorm normalized name: amphetamine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-amphetamine 10 mg
Trial: 31013226
Drug: Aspirin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (300 mg daily for up to 5 days before surgery)
Trial: 31013226
Drug: Medication-free group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-free group (no aspirin)
Trial: 30158152
Drug: Tenapanor (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenapanor (15 mg, given twice daily for 4 days)
Trial: 24569916
Drug: Neoadjuvant cisplatin‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant cisplatin‐based combination chemotherapy
Trial: 24569916
Drug: Cystectomy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cystectomy alone or surgery followed by adjuvant chemotherapy
Trial: 23230999
Drug: Doxylamine hydrogen
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxylamine hydrogen succinate 25 mg under fed conditions